Traduction de «human person » (Néerlandais → Français) :

TERMINOLOGIE

humane parainfluenzavirussen
virus para-influenza humainses

humane alfa-1-proteinase inhibitor
inhibiteur de la protéinase alpha 1 humaine

humane anti-D-immunoglobulinen
immunoglobuline humaine anti-D

TRADUCTIONS EN CONTEXTE

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

The law of 7 May 2004 relating to experiments on the human person in Belgium provides that any objections from the FAMHP need to be submitted within a maximum of 28 days following the validation of applications for clinical trials.
The law of 7 May 2004 relating to experiments on the human person in Belgium provides that any objections from the FAMHP need to be submitted within a maximum of 28 days following the validation of applications for clinical trials.

Francis S. Collins: The Language of Life: DNA and the Revolution in Personalized Medicine, Harper-Collins 2010, 368 p. Een inleiding over gepersonaliseerde geneeskunde geschreven door de directeur van het Amerikaanse National Institute of Health en voormalig directeur van het Human Genome Project
Francis S. Collins: The Language of Life: DNA and the Revolution in Personalized Medicine, Harper-Collins 2010, 368 p. Présentation de la médecine personnalisée rédigée par le directeur du National Institute of Health des États-Unis et ancien directeur du Human Genome Project

Roughly equivalent results are obtained in Nawrot et al., 2003, who carried out an exhaustive survey in 2003 that was exclusively devoted to the effects of caffeine on human health. The latter also shows that, in a healthy adult population, a moderate caffeine intake of up to 400 mg/day (which amounts to 6 mg/kg/day in a person weighing 65 kg) is not linked to such undesirable consequences as cardiovascular effects, effects on the bones and the calcium balance, behaviour changes, increased incidence of cancer and reduced male fertility.
Une revue exhaustive exclusivement consacrée aux effets de la caféine sur la santé humaine datant de 2003 donne des valeurs sensiblement équivalentes en signalant que dans une population adulte saine, un apport modéré en caféine dans un domaine allant jusqu’à 400 mg/jour (équivalent à 6 mg/kg/jour chez une personne de 65 kg) n’est pas associé à des effets indésirables tels que des effets cardiovasculaires, des effets sur l’os et la balance calcique, des modifications comportementales, une incidence accrue de cancers et des effets sur la fertilité masculine mais que les femmes en âge de procréer et les enfants constituent bien des sousgroupes à risque chez qui l’apport en caféine doit être tout spécialement réduit (Nawrot et al., 2003).